Emodin Inhibits the Proliferation of MCF-7 Human Breast Cancer Cells Through Activation of Aryl Hydrocarbon Receptor (AhR)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emodin Inhibits the Proliferation of MCF-7 Human Breast Cancer Cells Through Activation of Aryl Hydrocarbon Receptor (AhR)
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-19
DOI
10.3389/fphar.2020.622046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Investigation of candidate molecular biomarkers for expression profile analysis of the Gene expression omnibus (GEO) in acute lymphocytic leukemia (ALL)
- (2019) Guojun Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Synthesis, alkaline phosphatase inhibition studies and molecular docking of novel derivatives of 4-quinolones
- (2017) Mariia Miliutina et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel chemotypes targeting tubulin at the colchicine binding site and unbiasing P-glycoprotein
- (2017) Giuseppe Felice Mangiatordi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database
- (2017) Xia Wang et al. NUCLEIC ACIDS RESEARCH
- Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo
- (2017) Jingjing Lu et al. OncoTargets and Therapy
- Advances in bio-active constituents, pharmacology and clinical applications of rhubarb
- (2017) Yu-Jie Cao et al. Chinese Medicine
- AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity
- (2016) Eileen Brantley et al. CANCER LETTERS
- Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents
- (2016) Jeelan Basha Shaik et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation
- (2016) Theodoros Eleftheriadis et al. EXPERIMENTAL HEMATOLOGY
- The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible
- (2016) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The application of in silico drug-likeness predictions in pharmaceutical research
- (2015) Sheng Tian et al. ADVANCED DRUG DELIVERY REVIEWS
- OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
- (2015) Edward Harder et al. Journal of Chemical Theory and Computation
- Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
- (2015) P Khongkow et al. ONCOGENE
- Emodin induces apoptosis of human breast cancer cells by modulating the expression of apoptosis-related genes
- (2015) CONG ZU et al. Oncology Letters
- Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro
- (2015) Jie-yu Xing et al. PLoS One
- Emodin Inhibits Breast Cancer Cell Proliferation through the ERα-MAPK/Akt-Cyclin D1/Bcl-2 Signaling Pathway
- (2014) Jia-Qi Sui et al. Asian Pacific Journal of Cancer Prevention
- Emodin enhances osteogenesis and inhibits adipogenesis
- (2014) Feng Yang et al. BMC Complementary and Alternative Medicine
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo
- (2014) YANG SUN et al. ONCOLOGY REPORTS
- The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells
- (2014) E F O'Donnell et al. Cell Death & Disease
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
- (2014) Jinlong Ru et al. Journal of Cheminformatics
- Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling
- (2013) Chun Wang et al. CARCINOGENESIS
- Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERαInhibition
- (2013) Pao-Hsuan Huang et al. Evidence-based Complementary and Alternative Medicine
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Emodin induces cytotoxic effect in human breast carcinoma MCF-7 cell through modulating the expression of apoptosis-related genes
- (2013) Wing-Yan Li et al. PHARMACEUTICAL BIOLOGY
- The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
- (2012) Timothy V. Beischlag et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Dioxins and Human Toxicity
- (2010) Natalija Marinković et al. Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- Indole-3-Carbinol Triggers Aryl Hydrocarbon Receptor-dependent Estrogen Receptor (ER)α Protein Degradation in Breast Cancer Cells Disrupting an ERα-GATA3 Transcriptional Cross-Regulatory Loop
- (2010) Crystal N. Marconett et al. MOLECULAR BIOLOGY OF THE CELL
- Amino Acid Substitutions in the Aryl Hydrocarbon Receptor Ligand Binding Domain Reveal YH439 As an Atypical AhR Activator
- (2010) F. Whelan et al. MOLECULAR PHARMACOLOGY
- Protein–Protein Interactions Essentials: Key Concepts to Building and Analyzing Interactome Networks
- (2010) Javier De Las Rivas et al. PLoS Computational Biology
- Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
- (2009) Jen-Chung Ko et al. BIOCHEMICAL PHARMACOLOGY
- Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo
- (2009) Wang Chun-Guang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro
- (2009) Liu ONCOLOGY REPORTS
- The pleiotropy of dioxin toxicity — Xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles
- (2009) Sebastian G.B. Furness et al. PHARMACOLOGY & THERAPEUTICS
- Emodin-Induced Generation of Reactive Oxygen Species Inhibits RhoA Activation to Sensitize Gastric Carcinoma Cells to Anoikis
- (2008) Jun Cai et al. NEOPLASIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started